Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention

Mahmood, Zanjbeel; Patten, Ryan Van; Keller, Amber V.; Lykins, Hannah C.; Perivoliotis, Dimitri; Granholm, Eric; Twamley, Elizabeth W.

doi:10.1016/j.psychres.2020.113620

Cited by 11 publications

(9 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literatures without outcome indicators and with unusable data were further excluded. Finally, 14 literatures [8,9,[12][13][14][15][16][17][18][19][20][21][22][23] were included.…”

Section: Literature Screening Process and Resultsmentioning

confidence: 99%

“…Intervention. Among all 14 included studies, a total of 8 literatures [8,12,14,15,[20][21][22][23] tried to compare SCIT with TSU for the comparison of negative symptom scores of patients with schizophrenia after treatment, the literatures [8,14,21,22] were assessed by the SANS scale, and the literatures [12,15,20,23] were assessed by the negative symptom subscale of PANSS scale. In the analysis, it was found that there was significant heterogeneity between the literatures (tau 2 = 0:7979 (SE = 0:4864), I 2 = 92:62%, Cochran Q test, P < 0:0001).…”

Section: Comparison Of Negative Symptom Scores Aftermentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Social Cognitive Interaction Training on Schizophrenia: A Systematic Review and Meta-Analysis of Comparison with Conventional Treatment

Tang

Zhang

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

Background. Existing antipsychotic medications may alleviate the majority of patients’ symptoms, but they have no discernible impact on improving social function and quality of life. Psychotherapy is required for the treatment of schizophrenia. However, contemporary psychotherapy technology intervention techniques are limited to a single intervention, and there is a lack of holistic and complete intervention approaches. Social cognition and interaction training is a comprehensive therapy strategy that has been employed in clinical practice; however, the therapeutic efficacy has been inconsistently reported. As a result, we included controlled clinical trials for meta-analysis in order to carefully assess the efficacy of this therapy. Methods. This meta-analysis searched all RCT literatures related to social cognitive interaction training (SCIT) published before April 2022 and assessed the effect of this method in the treatment of schizophrenia. The data in the literatures were combined, and the standardized mean difference (SMD) and mean difference (MD) with 95% confidence interval (95% CI) were calculated to predict the negative symptom score, positive symptom score, PANSS score, and social function score of the patients after treatment. Results. 14 RCT studies including 1167 inpatients with schizophrenia were included in this study using a retrospective observational study method, including 590 patients treated with SCIT and 577 patients treated with treatment as usual (TAU). The pooled analysis showed that patients after SCIT had lower negative symptom scores ( SMD = − 1.66 , 95% CI (-2.32, -1.00), P < 0.0001 ), lower positive symptom scores ( MD = − 4.03 , 95% CI (-7.69, -0.36), P = 0.03 ), lower PANSS total scores ( MD = − 6.33 , 95% CI (-12.43, -0.23), P = 0.02 ), and higher social functioning scores ( SMD = 0.77 , 95% CI (0.34, 1.20), P < 0.001 ) than those after TAU. Conclusion. Our findings support that SCIT is helpful to improve the relief of symptoms and the improvement of social function in patients with schizophrenia, providing a basis for the application of SCIT in hospitalized patients and community patients, and can guide the treatment and intervention of patients with schizophrenia.

show abstract

“…The literatures without outcome indicators and with unusable data were further excluded. Finally, 14 literatures [8,9,[12][13][14][15][16][17][18][19][20][21][22][23] were included.…”

Section: Literature Screening Process and Resultsmentioning

confidence: 99%

Section: Comparison Of Negative Symptom Scores Aftermentioning

confidence: 99%

The Effect of Social Cognitive Interaction Training on Schizophrenia: A Systematic Review and Meta-Analysis of Comparison with Conventional Treatment

Tang

Zhang

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Given that the presence of negative symptoms has been associated with a lower level of functioning that may directly affect not only a patient's quality of life, but also aspects such as adherence and response to treatment [23,58], it is important to detect the disease in early stages of RA. Various psychotherapeutic and psychosocial interventions could prove useful for negative symptoms [59,60]. Undoubtedly, early use of these tools could play a role in patients' coping strategies and improve disease progress.…”

Section: Discussionmentioning

confidence: 99%

Assessment of Subclinical Psychotic Symptoms in Patients with Rheumatoid Arthritis and Spondyloarthritis

Prados-Ojeda

Luque-Luque

Gordillo-Urbano

et al. 2021

JCM

View full text Add to dashboard Cite

Inflammatory and autoimmune processes have been associated with the onset of depressive and psychotic symptoms. Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are rheumatic diseases with an inflammatory etiology. A high prevalence of depressive and anxiety-related comorbidity has been reported for both diseases, with no evidence of a greater prevalence of psychosis. The objective of the present study was to evaluate for the first time subclinical psychotic symptoms in patients with RA and SpA. This is a cross-sectional, single-center study including RA and SpA patients, as well as healthy controls. Abnormal psychotic experiences (positive, negative, and depressive symptoms) were evaluated using the Community Assessment of Psychic Experiences (CAPE-42). Functional capacity was evaluated using the Short-Form Health Survey SF-12. We compared the CAPE and SF-12 scores between the three groups. We recruited 385 individuals: 218 with RA, 100 with SpA, and 67 healthy controls. According to the CAPE scale, the frequency of subclinical psychotic symptoms was greater in patients than in healthy controls (RA, 1.90 vs. 1.63, p < 0.001; SpA, 1.88 vs. 1.63, p = 0.001). Distress was also greater in patients than in controls owing to the presence of symptoms. No differences were observed between the three groups for the mental dimension scores in the SF-12 Health Survey (43.75 in RA, 45.54 in SpA, and 43.19 in healthy controls). Our findings point to a greater prevalence of subclinical psychotic symptoms in patients with RA and patients with SpA than in the general population. The results suggest an association between inflammation and depression/subclinical psychotic symptoms.

show abstract

“…Today, psychoeducation based on CBT in individuals diagnosed with schizophrenia decreases both their internalized stigma and the stigma the society imposes on them by normalizing their viewpoint about the illness (Chiu et al, 2018; Mahmood et al, 2021; Rose et al, 2015). Thus, it contributes to the increase of their functionality level by enabling them to adapt to society and socialize more easily.…”

Section: Introductionmentioning

confidence: 99%

“…Thus, it contributes to the increase of their functionality level by enabling them to adapt to society and socialize more easily. Furthermore, these CBT‐based psychoeducation applications increase the functionality of individuals diagnosed with schizophrenia by decreasing the frequency and severity of psychotic symptoms such as delusions and hallucinations characteristic of this disorder (Chiu et al, 2018; Mahmood et al, 2021). Rose et al (2015) determined that CBT‐based training improves the functionality of individuals with schizophrenia.…”

Section: Introductionmentioning

confidence: 99%

The effect of cognitive behavioral therapy‐based psychoeducation on internalized stigma and functional remission in individuals diagnosed with schizophrenia

Çiftçi

Budak

2022

Perspect Psychiatric Care

View full text Add to dashboard Cite

Purpose: The aim of this study is to determine the effect of cognitive behavioral therapy-based psychoeducation provided to individuals diagnosed with schizophrenia on internalized stigma and functional remission.Design and Methods: The study was conducted based on the quasi-experimental design with pretest-posttest control group with 100 individuals, who were diagnosed with schizophrenia, in a Community Mental Health Center between September 2020 and June 2021.Findings: It was determined that after the cognitive behavioral therapy-based psychoeducation, the internalized stigma level decreased and the functional remission level increased in the experimental group compared with the control group.Practice Implications: In the study, it was determined that the experimental and control groups had low levels of functional remission and high levels of internalized stigma before the cognitive behavioral therapy-based psychoeducation, and the functional remission levels increased and the internalized stigma levels decreased in the experimental group compared with the control group after the cognitive behavioral therapy-based psychoeducation.

show abstract

Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention

Cited by 11 publications

References 73 publications

The Effect of Social Cognitive Interaction Training on Schizophrenia: A Systematic Review and Meta-Analysis of Comparison with Conventional Treatment

The Effect of Social Cognitive Interaction Training on Schizophrenia: A Systematic Review and Meta-Analysis of Comparison with Conventional Treatment

Assessment of Subclinical Psychotic Symptoms in Patients with Rheumatoid Arthritis and Spondyloarthritis

The effect of cognitive behavioral therapy‐based psychoeducation on internalized stigma and functional remission in individuals diagnosed with schizophrenia

Contact Info

Product

Resources

About